lixivaptan has been researched along with opc 21268 in 1 studies
Studies (lixivaptan) | Trials (lixivaptan) | Recent Studies (post-2010) (lixivaptan) | Studies (opc 21268) | Trials (opc 21268) | Recent Studies (post-2010) (opc 21268) |
---|---|---|---|---|---|
80 | 10 | 26 | 133 | 3 | 6 |
Protein | Taxonomy | lixivaptan (IC50) | opc 21268 (IC50) |
---|---|---|---|
Vasopressin V1a receptor | Rattus norvegicus (Norway rat) | 0.44 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
1 review(s) available for lixivaptan and opc 21268
Article | Year |
---|---|
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |